239 related articles for article (PubMed ID: 12009508)
21. Effects of raloxifene and estradiol on hippocampal acetylcholine release and spatial learning in the rat.
Gibbs RB; Gabor R; Cox T; Johnson DA
Psychoneuroendocrinology; 2004 Jul; 29(6):741-8. PubMed ID: 15110923
[TBL] [Abstract][Full Text] [Related]
22. No effect of different estrogen receptor ligands on cognition in adult female monkeys.
Lacreuse A; Wilson ME; Herndon JG
Physiol Behav; 2009 Mar; 96(3):448-56. PubMed ID: 19101578
[TBL] [Abstract][Full Text] [Related]
23. Raloxifene recovers effects of prenatal immune activation on cognitive task-induced gamma power.
Schroeder A; Nakamura JP; Hudson M; Jones NC; Du X; Sundram S; Hill RA
Psychoneuroendocrinology; 2019 Dec; 110():104448. PubMed ID: 31546114
[TBL] [Abstract][Full Text] [Related]
24. The effect of raloxifene on coronary arteries in aged ovariectomized ewes.
Gaynor JS; Monnet E; Selzman C; Parker D; Kaufman L; Bryant HU; Mallinckrodt C; Wrigley R; Whitehill T; Turner AS
J Vet Pharmacol Ther; 2000 Jun; 23(3):175-9. PubMed ID: 11110106
[TBL] [Abstract][Full Text] [Related]
25. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate.
Frolik CA; Bryant HU; Black EC; Magee DE; Chandrasekhar S
Bone; 1996 Jun; 18(6):621-7. PubMed ID: 8806005
[TBL] [Abstract][Full Text] [Related]
26. Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.
Liu H; Lee ES; Gajdos C; Pearce ST; Chen B; Osipo C; Loweth J; McKian K; De Los Reyes A; Wing L; Jordan VC
J Natl Cancer Inst; 2003 Nov; 95(21):1586-97. PubMed ID: 14600091
[TBL] [Abstract][Full Text] [Related]
27. Selective estrogen receptor modulators decrease reactive astrogliosis in the injured brain: effects of aging and prolonged depletion of ovarian hormones.
Barreto G; Santos-Galindo M; Diz-Chaves Y; Pernía O; Carrero P; Azcoitia I; Garcia-Segura LM
Endocrinology; 2009 Nov; 150(11):5010-5. PubMed ID: 19797123
[TBL] [Abstract][Full Text] [Related]
28. Patterns of cognitive decline in aged rhesus monkeys.
Herndon JG; Moss MB; Rosene DL; Killiany RJ
Behav Brain Res; 1997 Aug; 87(1):25-34. PubMed ID: 9331471
[TBL] [Abstract][Full Text] [Related]
29. Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats.
Wang XN; Simmons HA; Salatto CT; Cosgrove PG; Thompson DD
Menopause; 2006; 13(4):609-20. PubMed ID: 16837883
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of intimal hyperplasia using the selective estrogen receptor modulator raloxifene.
Selzman CH; Turner AS; Gaynor JS; Miller SA; Monnet E; Harken AH
Arch Surg; 2002 Mar; 137(3):333-6. PubMed ID: 11888462
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of estradiol, methyl-piperidino-pyrazole, raloxifene, and ICI 182 780 on gene expression in the murine uterus.
Davis AM; Mao J; Naz B; Kohl JA; Rosenfeld CS
J Mol Endocrinol; 2008 Oct; 41(4):205-17. PubMed ID: 18632874
[TBL] [Abstract][Full Text] [Related]
32. Timing of cyclic estradiol treatment differentially affects cognition in aged female rhesus monkeys.
Baxter MG; Santistevan AC; Bliss-Moreau E; Morrison JH
Behav Neurosci; 2018 Aug; 132(4):213-223. PubMed ID: 29952604
[TBL] [Abstract][Full Text] [Related]
33. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
Gogos A; van den Buuse M
Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of selective estrogen receptor modulators and estrogens on mammary blood flow in the ovine.
Zoma WD; Baker RS; Kopernik G; Mershon JL; Clark KE
Am J Obstet Gynecol; 2002 Dec; 187(6):1555-60. PubMed ID: 12501063
[TBL] [Abstract][Full Text] [Related]
35. Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain.
Landry M; Lévesque D; Di Paolo T
Neuroendocrinology; 2002 Oct; 76(4):214-22. PubMed ID: 12411738
[TBL] [Abstract][Full Text] [Related]
36. Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease.
O'Neill K; Chen S; Brinton RD
Exp Neurol; 2004 Jan; 185(1):63-80. PubMed ID: 14697319
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets.
Jayachandran M; Mukherjee R; Steinkamp T; LaBreche P; Bracamonte MP; Okano H; Owen WG; Miller VM
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2355-62. PubMed ID: 15653758
[TBL] [Abstract][Full Text] [Related]
38. A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium.
Goldstein SR; Scheele WH; Rajagopalan SK; Wilkie JL; Walsh BW; Parsons AK
Obstet Gynecol; 2000 Jan; 95(1):95-103. PubMed ID: 10636510
[TBL] [Abstract][Full Text] [Related]
39. A long-term cyclic plus tonic regimen of 17β-estradiol improves the ability to handle a high spatial working memory load in ovariectomized middle-aged female rats.
Koebele SV; Nishimura KJ; Bimonte-Nelson HA; Kemmou S; Ortiz JB; Judd JM; Conrad CD
Horm Behav; 2020 Feb; 118():104656. PubMed ID: 31862208
[TBL] [Abstract][Full Text] [Related]
40. Effects of estradiol and raloxifene on arterial thrombosis in ovariectomized mice.
Abu-Fanne R; Brzezinski A; Golomb M; Grad E; Foldes AJ; Shufaro Y; Varon D; Brill A; Lotan C; Danenberg HD
Menopause; 2008; 15(1):98-104. PubMed ID: 17549036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]